Semax nootropic ACTH-derived research peptide vial 10mg — RETA UK

Semax

10mg
£30.00
Sale price  £30.00 Regular price 
Skip to product information
Semax nootropic ACTH-derived research peptide vial 10mg — RETA UK

Semax

★★★★ 4.7 · 200+ orders served

Semax is a research-grade synthetic heptapeptide derived from the 4-7 fragment of adrenocorticotropic hormone (ACTH), modified with a Pro-Gly-Pro tripeptide extension that enhances stability and bioactivity. It is one of the most extensively studied nootropic peptides in Russian neuroscience literature, recognised for its capacity to upregulate brain-derived neurotrophic factor (BDNF) and modulate central neurotransmitter systems including dopamine, serotonin, and acetylcholine.

Available in 10mg and 30mg vials. Every batch is HPLC tested and independently verified to a minimum of 99% purity. Certificate of Analysis available on request.

Research applications include:

  • BDNF upregulation and neurotrophic factor pathway modulation studies
  • Cognitive function, memory consolidation and learning research models
  • Neuroprotective mechanism investigation against hypoxia and oxidative stress
  • Neurotransmitter system modulation (dopaminergic, serotonergic, cholinergic)
  • Enkephalin degradation inhibition and endogenous opioid pathway research
  • Comparative nootropic peptide research vs Selank and other CNS compounds

Product specifications:

  • Form: Lyophilised powder
  • Purity: ≥99% (HPLC verified)
  • Storage: −20°C, protected from light and moisture
  • Available sizes: 10mg · 30mg
  • Origin: UK warehouse, same day dispatch
Size
Multibuy Discount Available
Buy 2 save 5% Buy 3 save 10% Buy 4 save 15% Buy 5+ save 20%
£30.00
Sale price  £30.00 Regular price 
✓ 99%+ Purity Guaranteed ✓ COA Available ✓ Same Day UK Dispatch ✓ Secure Checkout
For research purposes only. This product is not intended for human or veterinary use, consumption, or self-administration. Must be handled by qualified professionals in a suitable laboratory environment. Not evaluated by the MHRA or any regulatory authority for therapeutic use. Read full disclaimer →

You may also like